Tearsheet

Cerence (CRNC)


Market Price (11/14/2025): $8.55 | Market Cap: $369.9 Mil
Sector: Information Technology | Industry: Application Software

Cerence (CRNC)


Market Price (11/14/2025): $8.55
Market Cap: $369.9 Mil
Sector: Information Technology
Industry: Application Software

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 22%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%
Weak multi-year price returns
2Y Excs Rtn is -102%, 3Y Excs Rtn is -125%
Stock price has recently run up significantly
12M Rtn12 month market price return is 169%
1 Attractive yield
FCF Yield is 11%
Meaningful short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 17%
Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -31%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -8.6%, Rev Chg QQuarterly Revenue Change % is -12%
2 Megatrend and thematic drivers
Megatrends include Artificial Intelligence, and Electric Vehicles & Autonomous Driving. Themes include AI Software Platforms, Edge AI, Show more.
  Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -11%
3   High stock price volatility
Vol 12M is 204%
0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 22%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%
1 Attractive yield
FCF Yield is 11%
2 Megatrend and thematic drivers
Megatrends include Artificial Intelligence, and Electric Vehicles & Autonomous Driving. Themes include AI Software Platforms, Edge AI, Show more.
3 Weak multi-year price returns
2Y Excs Rtn is -102%, 3Y Excs Rtn is -125%
4 Meaningful short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 17%
5 Stock price has recently run up significantly
12M Rtn12 month market price return is 169%
6 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -31%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -8.6%, Rev Chg QQuarterly Revenue Change % is -12%
7 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -11%
8 High stock price volatility
Vol 12M is 204%

Market Valuation & Key Metrics

CRNC Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

The public company Cerence (CRNC) experienced a stock movement of -0.7% for the approximate period from July 31, 2025, to November 14, 2025. This slight decline can be attributed to a combination of positive financial performance and strategic advancements being weighed against year-over-year revenue challenges and cautious future projections. 1. Strong Third Quarter Fiscal Year 2025 Earnings Performance. On August 6, 2025, Cerence announced robust financial results for its third fiscal quarter of 2025, exceeding its guidance for both revenue and Adjusted EBITDA. The company reported revenue of $62.2 million and an Adjusted EBITDA of $9.0 million, along with its fifth consecutive quarter of positive free cash flow.

2. Raised Full Fiscal Year 2025 Guidance. Following the better-than-expected Q3 results, Cerence raised and narrowed its full fiscal year 2025 revenue guidance to a range of $244 million to $249 million, demonstrating management's confidence in its operational execution and market position.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
CRNC Return344%-24%-76%6%-60%9%-62%
Peers Return13%-2%-7%6%52%-26%25%
S&P 500 Return16%27%-19%24%23%15%109%

Monthly Win Rates [3]
CRNC Win Rate67%58%33%58%50%50% 
Peers Win Rate13%10%5%21%33%43% 
S&P 500 Win Rate58%75%42%67%75%70% 

Max Drawdowns [4]
CRNC Max Drawdown-41%-31%-82%-20%-88%-12% 
Peers Max Drawdown-5%-4%-8%-1%-4%-34% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: ADSK, HIT, BIYA, BLIV, BMR.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 11/13/2025 (YTD)

How Low Can It Go

Unique KeyEventCRNCS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-89.4%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven846.3%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-49.5%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven98.1%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven62 days148 days

Compare to ADSK, HIT, BIYA, BLIV, BMR


In The Past

Cerence's stock fell -89.4% during the 2022 Inflation Shock from a high on 2/12/2021. A -89.4% loss requires a 846.3% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Cerence (CRNC)

Better Bets than Cerence (CRNC)

Latest Trefis Analyses

Title
0ARTICLES

Trade Ideas

Select past ideas related to CRNC. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ZBRA_10312025_Dip_Buyer_FCFYield10312025ZBRAZebra TechnologiesDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
-5.0%-5.0%-5.2%
ACN_10312025_Dip_Buyer_ValueBuy10312025ACNAccentureDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-1.4%-1.4%-3.5%
ADBE_10312025_Dip_Buyer_ValueBuy10312025ADBEAdobeDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-1.0%-1.0%-3.9%
TXN_10312025_Monopoly_xInd_xCD_Getting_Cheaper10312025TXNTexas InstrumentsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
1.0%1.0%-1.3%
MRVL_10242025_Monopoly_xInd_xCD_Getting_Cheaper10242025MRVLMarvell TechnologyMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
6.2%6.2%0.0%
CRNC_1312022_Dip_Buyer_High_CFO_Margins_ExInd_DE01312022CRNCCerenceDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-55.6%-61.4%-77.8%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ZBRA_10312025_Dip_Buyer_FCFYield10312025ZBRAZebra TechnologiesDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
-5.0%-5.0%-5.2%
ACN_10312025_Dip_Buyer_ValueBuy10312025ACNAccentureDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-1.4%-1.4%-3.5%
ADBE_10312025_Dip_Buyer_ValueBuy10312025ADBEAdobeDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-1.0%-1.0%-3.9%
TXN_10312025_Monopoly_xInd_xCD_Getting_Cheaper10312025TXNTexas InstrumentsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
1.0%1.0%-1.3%
MRVL_10242025_Monopoly_xInd_xCD_Getting_Cheaper10242025MRVLMarvell TechnologyMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
6.2%6.2%0.0%
CRNC_1312022_Dip_Buyer_High_CFO_Margins_ExInd_DE01312022CRNCCerenceDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-55.6%-61.4%-77.8%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Cerence

Financials

CRNCADSKHITBIYABLIVBMRMedian
NameCerence Autodesk Health I.Baiya In.BeLive Beamr Im. 
Mkt Price8.54297.171.570.333.602.062.83
Mkt Cap0.463.30.1---0.4
Rev LTM2466,60527---246
Op Inc LTM51,5151---5
FCF LTM421,8471---42
FCF 3Y Avg151,704----859
CFO LTM551,9254---55
CFO 3Y Avg231,775----899

Growth & Margins

CRNCADSKHITBIYABLIVBMRMedian
NameCerence Autodesk Health I.Baiya In.BeLive Beamr Im. 
Rev Chg LTM-31.2%13.8%29.7%---13.8%
Rev Chg 3Y Avg-8.6%11.7%----1.5%
Rev Chg Q-11.8%17.1%86.2%---17.1%
QoQ Delta Rev Chg LTM-3.3%4.1%19.3%---4.1%
Op Mgn LTM2.2%22.9%5.0%---5.0%
Op Mgn 3Y Avg2.2%21.5%----11.9%
QoQ Delta Op Mgn LTM-1.4%0.8%-0.1%----0.1%
CFO/Rev LTM22.2%29.1%13.5%---22.2%
CFO/Rev 3Y Avg8.4%30.7%----19.6%
FCF/Rev LTM17.0%28.0%4.9%---17.0%
FCF/Rev 3Y Avg5.4%29.5%----17.4%

Valuation

CRNCADSKHITBIYABLIVBMRMedian
NameCerence Autodesk Health I.Baiya In.BeLive Beamr Im. 
Mkt Cap0.463.30.1---0.4
P/S1.59.63.3---3.3
P/EBIT-30.544.843.9---43.9
P/E-14.360.763.9---60.7
P/CFO6.832.924.2---24.2
Total Yield-7.0%1.6%1.6%---1.6%
Dividend Yield0.0%0.0%0.0%---0.0%
FCF Yield 3Y Avg7.6%3.3%----5.4%
D/E0.60.00.0---0.0
Net D/E0.40.0-0.1---0.0

Returns

CRNCADSKHITBIYABLIVBMRMedian
NameCerence Autodesk Health I.Baiya In.BeLive Beamr Im. 
1M Rtn-34.7%-3.1%-55.1%-36.8%-1.6%-30.9%-32.8%
3M Rtn-33.0%4.7%-51.5%-41.9%34.6%-35.2%-34.1%
6M Rtn-8.2%0.5%134.3%-93.4%-25.2%-23.7%-15.9%
12M Rtn168.6%-5.1%----24.5%-5.1%
3Y Rtn-51.9%33.1%-----9.4%
1M Excs Rtn-30.2%-3.6%-53.6%-39.3%-2.4%-28.2%-29.2%
3M Excs Rtn-32.3%-0.8%-59.9%-47.7%26.4%-36.9%-34.6%
6M Excs Rtn-22.0%-13.4%120.5%-107.3%-39.0%-37.6%-29.8%
12M Excs Rtn136.0%-17.6%----42.9%-17.6%
3Y Excs Rtn-125.0%-26.7%-----75.8%

Financials

Price Behavior

Short Interest

Short Interest: As Of Date10312025
Short Interest: Shares Quantity7,161,027
Short Interest: % Change Since 101520253.3%
Average Daily Volume1,129,333
Days-to-Cover Short Interest6.34
Basic Shares Quantity43,262,000
Short % of Basic Shares16.6%

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
5/7/2025-12.2%-4.3%1.8%
2/6/202513.7%14.0%-26.8%
11/21/2024106.7%137.2%172.0%
8/8/202416.9%2.3%23.2%
5/9/2024-34.3%-49.3%-68.2%
2/6/2024-7.1%-17.3%-29.9%
11/27/2023-2.1%1.7%15.7%
8/8/20234.0%3.7%-2.6%
...
SUMMARY STATS   
# Positive111313
# Negative1199
Median Positive12.1%14.0%21.0%
Median Negative-12.2%-17.3%-29.9%
Max Positive106.7%137.2%172.0%
Max Negative-34.3%-49.3%-68.2%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025806202510-Q 6/30/2025
3312025507202510-Q 3/31/2025
12312024206202510-Q 12/31/2024
93020241125202410-K 9/30/2024
6302024809202410-Q 6/30/2024
3312024510202410-Q 3/31/2024
12312023208202410-Q 12/31/2023
93020231129202310-K 9/30/2023
6302023809202310-Q 6/30/2023
3312023509202310-Q 3/31/2023
12312022208202310-Q 12/31/2022
93020221129202210-K 9/30/2022
6302022809202210-Q 6/30/2022
3312022510202210-Q 3/31/2022
12312021208202210-Q 12/31/2021
93020211123202110-K 9/30/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value
Value of
Held Shares
Form
0Mentz ChristianEVP, Chief Revenue Officer8182025Sell12.744,00050,9431,767,054Form
1Mentz ChristianEVP, Chief Revenue Officer2252025Sell14.733,60053,0282,102,663Form
2BEAUDOIN THOMAS L 2042025Sell11.685,00058,4002,031,923Form
3BEAUDOIN THOMAS L 1022025Sell7.985,00039,9001,428,149Form
4BEAUDOIN THOMAS L 12032024Sell7.365,00036,8001,353,990Form